Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
biotech
3
×
drug prices
3
×
gene therapy
3
×
life sciences
national
national blog main
national top stories
new york top stories
novartis
3
×
san francisco top stories
abbvie
alzheimer's disease
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
clinical trials
deals
detroit blog main
detroit top stories
diagnostics
generic drugs
gilead sciences
glaxosmithkline
immunotherapy
indiana blog main
indiana top stories
kaiser family foundation
medicare
merck
new york blog main
pembrolizumab
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
san francisco blog main
What
drug
3
×
bio
new
patients
roundup
acquisitions
albert
approval
approved
atrophy
biggest
biogen’s
biopharmaceutical
bourla
ceo
companies
company
convo
crispr
daily
earlier
evrysdi
failures
fda
friday
future
green
home
imports
intended
lights
liquid
littered
maker
maps
measured
medicine
muscular
nash
news
Language
unknown
unset
Current search:
drug
×
biotech
×
novartis
×
" drug prices "
×
" gene therapy "
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More